Treatment outlook for adults with hypertrophic cardiomyopathy move from grim to good
Wednesday, March 11, 2015 - 16:40
in Health & Medicine
Implantable defibrillators, along with other modern treatments, have reduced mortality rates and are helping patients with hypertrophic cardiomyopathy live longer, a study confirms. This research 'changes our perceptions of HCM from a grim, unrelenting, and largely untreatable condition to a contemporary disease with effective treatment options and a low rate of death,' states the lead researcher.